Contact
Please use this form to send email to PR contact of this press release:
Ultragenyx Announces Orphan Drug Designation for UX701 for the Treatment of Wilson Disease
TO:
Please use this form to send email to PR contact of this press release:
Ultragenyx Announces Orphan Drug Designation for UX701 for the Treatment of Wilson Disease
TO: